UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The lancet oncology, ISSN 1470-2045, 2016, Volume 18, Issue 1, pp. 75 - 87
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Ovarian Neoplasms - pathology | Salvage Therapy | Neoplasm Recurrence, Local - drug therapy | Germ-Line Mutation - genetics | Neoplasm Recurrence, Local - pathology | Ovarian Neoplasms - genetics | Neoplasms, Glandular and Epithelial - genetics | Peritoneal Neoplasms - drug therapy | Fallopian Tube Neoplasms - genetics | Female | Antineoplastic Agents - pharmacology | Poly(ADP-ribose) Polymerases - chemistry | Ovarian Neoplasms - drug therapy | Platinum - pharmacology | Fallopian Tube Neoplasms - drug therapy | Peritoneal Neoplasms - pathology | Neoplasms, Glandular and Epithelial - pathology | Fallopian Tube Neoplasms - pathology | Survival Rate | Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use | BRCA1 Protein - genetics | International Agencies | Peritoneal Neoplasms - genetics | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Indoles - therapeutic use | Neoplasm Recurrence, Local - genetics | Aged | Neoplasm Staging | BRCA2 Protein - genetics | Drug Resistance, Neoplasm - drug effects | Sugars | Monosaccharides | Ovarian cancer | Analysis | Carcinoma | Cancer | Index Medicus
Journal Article
The American journal of surgical pathology, ISSN 0147-5185, 02/2007, Volume 31, Issue 2, pp. 161 - 169
Serous carcinoma | BRCA | Fallopian tube neoplasms | Ovarian neoplasms | Intraepithelial carcinoma | Pathology | Life Sciences & Biomedicine | Surgery | Science & Technology | Biological and medical sciences | Investigative techniques, diagnostic techniques (general aspects) | Medical sciences | Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques | Humans | Cystadenocarcinoma, Serous - metabolism | Ovarian Neoplasms - pathology | Cystadenocarcinoma, Serous - genetics | Cystadenocarcinoma, Serous - pathology | Ovarian Neoplasms - genetics | Carcinoma in Situ - genetics | Fallopian Tube Neoplasms - genetics | Female | Ovarian Neoplasms - metabolism | Neoplasms, Second Primary - genetics | Pelvic Neoplasms - pathology | Peritoneal Neoplasms - pathology | Carcinoma in Situ - pathology | Pelvic Neoplasms - genetics | Tumor Suppressor Protein p53 - metabolism | Fallopian Tube Neoplasms - pathology | Genes, p53 - genetics | Neoplasms, Second Primary - metabolism | Peritoneal Neoplasms - genetics | Peritoneal Neoplasms - metabolism | Fallopian Tube Neoplasms - metabolism | Mutation | Carcinoma in Situ - metabolism | Precancerous Conditions | Neoplasms, Second Primary - pathology | Index Medicus
Journal Article
Modern pathology, ISSN 0893-3952, 08/2015, Volume 28, Issue 8, pp. 1101 - 1122
Life Sciences & Biomedicine | Pathology | Science & Technology | Predictive Value of Tests | Humans | Ovarian Neoplasms - pathology | Immunohistochemistry - standards | Carcinoma - chemistry | Peritoneal Neoplasms - chemistry | Ovarian Neoplasms - genetics | Peritoneal Neoplasms - drug therapy | Neoplasm Grading | Fallopian Tube Neoplasms - chemistry | Fallopian Tube Neoplasms - genetics | Female | Molecular Diagnostic Techniques - standards | Neoadjuvant Therapy | Chemotherapy, Adjuvant | Carcinoma - pathology | Ovarian Neoplasms - drug therapy | Fallopian Tube Neoplasms - drug therapy | Carcinoma - drug therapy | Peritoneal Neoplasms - pathology | Pathology, Clinical - standards | Diagnosis, Differential | Ovarian Neoplasms - chemistry | Biopsy - standards | Biomarkers, Tumor - analysis | Carcinoma - surgery | Peritoneal Neoplasms - surgery | Fallopian Tube Neoplasms - pathology | Fallopian Tube Neoplasms - surgery | Peritoneal Neoplasms - genetics | Carcinoma - genetics | Research Design - standards | Biomarkers, Tumor - genetics | Neoplasm Staging | Ovarian Neoplasms - surgery | Index Medicus
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 01/2019, Volume 107, pp. 164 - 174
Biomarker | Molecular diagnostics | Temozolomide | MGMT | Colorectal cancer | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Prognosis | Follow-Up Studies | Colorectal Neoplasms - genetics | Humans | Lung Neoplasms - metabolism | Middle Aged | DNA Repair Enzymes - genetics | Neoplasm Recurrence, Local - drug therapy | Male | Biomarkers, Tumor | Patient Selection | Neoplasm Recurrence, Local - pathology | Temozolomide - therapeutic use | DNA Methylation | Peritoneal Neoplasms - drug therapy | Lung Neoplasms - secondary | Colorectal Neoplasms - drug therapy | Tumor Suppressor Proteins - genetics | DNA Repair Enzymes - metabolism | Aged, 80 and over | Female | Retrospective Studies | Liver Neoplasms - secondary | Colorectal Neoplasms - metabolism | Peritoneal Neoplasms - secondary | Lung Neoplasms - genetics | Tumor Suppressor Proteins - metabolism | DNA Modification Methylases - metabolism | Liver Neoplasms - genetics | Neoplasm Recurrence, Local - metabolism | Liver Neoplasms - drug therapy | Survival Rate | Proteome - analysis | Antineoplastic Agents, Alkylating - therapeutic use | DNA Modification Methylases - genetics | Peritoneal Neoplasms - genetics | Peritoneal Neoplasms - metabolism | Liver Neoplasms - metabolism | Neoplasm Recurrence, Local - genetics | Aged | Colorectal Neoplasms - pathology | Proteome - metabolism | Yuan (China) | Care and treatment | RNA | Transferases | Metastasis | Antineoplastic agents | Antimitotic agents | Cancer patients | Gliomas | Analysis | DNA | Genetic research | Genetic aspects | Drug therapy | Methylation | Mass spectrometry | Cancer | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 07/2012, Volume 30, Issue 21, pp. 2654 - 2663
Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Biological and medical sciences | Medical sciences | Tumors | Female genital diseases | Medical History Taking | Recurrence | Prospective Studies | Humans | Middle Aged | Ovarian Neoplasms - pathology | Drug Resistance, Neoplasm | Cystadenocarcinoma, Serous - genetics | Cystadenocarcinoma, Serous - drug therapy | Case-Control Studies | Ovarian Neoplasms - genetics | Peritoneal Neoplasms - drug therapy | Neoplasm Grading | Fallopian Tube Neoplasms - genetics | Aged, 80 and over | Genes, BRCA2 | Germ-Line Mutation | Adult | Female | Genes, BRCA1 | Ovarian Neoplasms - drug therapy | Fallopian Tube Neoplasms - drug therapy | Carcinoma - drug therapy | Carcinoma, Endometrioid - genetics | Kaplan-Meier Estimate | Mutation Rate | Treatment Outcome | Carcinoma, Endometrioid - drug therapy | Australia - epidemiology | Ovarian Neoplasms - epidemiology | Disease-Free Survival | Point Mutation | Breast Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Peritoneal Neoplasms - genetics | Carcinoma - genetics | Aged | Platinum Compounds - administration & dosage | Neoplasm Staging | Adenocarcinoma, Clear Cell - genetics | Adenocarcinoma, Clear Cell - drug therapy | Cohort Studies | Index Medicus | Original Reports | Gynecologic Cancer | Gync21 | Gync15
Journal Article
Cancer cell, ISSN 1535-6108, 2011, Volume 19, Issue 1, pp. 31 - 44
Clodronic Acid - pharmacology | Gene Expression - genetics | Dendritic Cells - immunology | Humans | Pregnancy Proteins - genetics | Microvessels - pathology | Pregnancy Proteins - metabolism | Chemotactic Factors - metabolism | Neoplasm Metastasis - immunology | Antibodies - immunology | Neovascularization, Pathologic - immunology | Macrophages, Peritoneal - drug effects | Macrophages - pathology | Neoplasms - blood supply | Down-Regulation - genetics | Mice, Knockout | Macrophages - metabolism | Neoplasms - immunology | Cell Line, Tumor | Placenta Growth Factor | Mice | Mice, Inbred BALB C | CD8-Positive T-Lymphocytes - immunology | Macrophages, Peritoneal - metabolism | Neoplasms - metabolism | CD8-Positive T-Lymphocytes - pathology | Gene Expression - drug effects | Regional Blood Flow - genetics | Dendritic Cells - pathology | Culture Media, Conditioned - pharmacology | Lung Neoplasms - pathology | Hypoxia - metabolism | Neovascularization, Pathologic - pathology | Regional Blood Flow - drug effects | Transfection | Lung Neoplasms - secondary | Neoplasms - genetics | Dendritic Cells - metabolism | Macrophages - immunology | Lung Neoplasms - genetics | Microvessels - ultrastructure | Cytokines - metabolism | Mice, Inbred C57BL | Microvessels - drug effects | Pregnancy Proteins - immunology | Antibodies - pharmacology | Proteins - genetics | Neoplasm Metastasis - genetics | Hypoxia - genetics | Lung Neoplasms - immunology | Animals | Proteins - metabolism | Endothelial Cells - cytology | Neoplasm Metastasis - pathology | Macrophages - drug effects | Neovascularization, Pathologic - genetics | Cell Proliferation - drug effects | Proteins - pharmacology | Neoplasms - pathology | Endothelial Cells - drug effects | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 2014, Volume 32, Issue 15, pp. 1547 - 1553
Life Sciences & Biomedicine | Oncology | Science & Technology | Ovariectomy - adverse effects | Age Factors | Humans | Middle Aged | Ovarian Neoplasms - pathology | Ovarian Neoplasms - mortality | North America | Incidence | Ovarian Neoplasms - genetics | Time Factors | Fallopian Tube Neoplasms - genetics | Aged, 80 and over | Adult | Female | Registries | Surveys and Questionnaires | Odds Ratio | Peritoneal Neoplasms - pathology | Fallopian Tube Neoplasms - prevention & control | Genetic Predisposition to Disease | Ovarian Neoplasms - prevention & control | Risk Assessment | Europe | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Fallopian Tube Neoplasms - pathology | Treatment Outcome | Peritoneal Neoplasms - prevention & control | Peritoneal Neoplasms - mortality | BRCA1 Protein - genetics | Ovariectomy - mortality | Phenotype | Fallopian Tube Neoplasms - mortality | Peritoneal Neoplasms - genetics | Aged | Mutation | BRCA2 Protein - genetics | Index Medicus | Gync21 | Bios4 | Bc3 | ORIGINAL REPORTS | Gync15
Journal Article
Nature (London), ISSN 0028-0836, 10/2010, Volume 467, Issue 7319, pp. 1114 - 1117
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Biological and medical sciences | Medical sciences | Liver. Biliary tract. Portal circulation. Exocrine pancreas | Tumors | Adenocarcinoma - pathology | Humans | Lung Neoplasms - secondary | Time Factors | Autopsy | DNA Mutational Analysis | Adenocarcinoma - genetics | Liver Neoplasms - secondary | Cell Lineage - genetics | Peritoneal Neoplasms - secondary | Lung Neoplasms - genetics | Liver Neoplasms - genetics | Early Detection of Cancer | Pancreatic Neoplasms - pathology | Pancreas - pathology | Pancreatic Neoplasms - genetics | Pancreas - metabolism | Mutation - genetics | Clone Cells - metabolism | Disease Progression | Neoplasm Metastasis - genetics | Clone Cells - pathology | Models, Biological | Neoplasm Metastasis - pathology | Peritoneal Neoplasms - genetics | Evolution, Molecular | Genetic aspects | Metastasis | Research | Pancreatic cancer | Mutation | Pancreas | Cancer | Index Medicus
Journal Article
Oncology, ISSN 0030-2414, 12/2012, Volume 84, Issue 2, pp. 81 - 91
Clinical Translational Research | Integrin | Colorectal carcinoma | Osteonectin | Biomarkers | Osteopontin | Extracellular matrix | Carcinogenesis | Fibronectin | Life Sciences & Biomedicine | Oncology | Science & Technology | Adenocarcinoma - pathology | Follow-Up Studies | Colorectal Neoplasms - genetics | Humans | Lung Neoplasms - metabolism | Middle Aged | Male | Immunoenzyme Techniques | Ovarian Neoplasms - genetics | Young Adult | Ovarian Neoplasms - secondary | Adenocarcinoma - metabolism | Aged, 80 and over | Biomarkers, Tumor - metabolism | Ovarian Neoplasms - metabolism | Liver Neoplasms - secondary | Real-Time Polymerase Chain Reaction | Integrin alphaV - metabolism | Tumor Suppressor Proteins - metabolism | Liver Neoplasms - genetics | Lymphatic Metastasis | Reverse Transcriptase Polymerase Chain Reaction | Peritoneal Neoplasms - metabolism | Liver Neoplasms - metabolism | Biomarkers, Tumor - genetics | Integrin alpha5 - genetics | Osteopontin - genetics | Prognosis | Tissue Array Analysis | Osteopontin - metabolism | Lung Neoplasms - secondary | Tumor Suppressor Proteins - genetics | Adult | Female | Adenocarcinoma - genetics | Integrin alphaV - genetics | Colorectal Neoplasms - metabolism | Peritoneal Neoplasms - secondary | Lung Neoplasms - genetics | Neoplasm Invasiveness | RNA, Messenger - genetics | Fibronectins - metabolism | Peritoneal Neoplasms - genetics | Integrin alpha5 - metabolism | Aged | Fibronectins - genetics | Colorectal Neoplasms - pathology | Neoplasm Staging | Cellular biology | Gene expression | Colorectal cancer | Tumors | Index Medicus
Journal Article